Article -> Article Details

Market Analysis 

The plastic surgery and integumentary system procedures market is predicted to grow at a healthy CAGR between 2016-2022, states the latest Market Research Future (MRFR) report. Plastic surgery, simply put, is a medical process to restore, correct, or alter skin on different parts of the body. It is generally performed as a cosmetic or reconstructive procedure. On the other hand, the integumentary system, simply put, is an organ framework that includes skin as well as its extremities, which protects the body against various forms of damages. It is mostly done for skin cancer, herpes, rabies, athlete’s foot, rubella, psoriasis, acne, rash, sunburn, and infection.

Various factors are propelling the plastic surgery and integumentary system procedures market growth. These factors as stated by the latest Market Research Future report, include growing demand for procedures especially cryosurgery, chemobrasion, and laser therapy, the influence of social media, increasing media exposure, increasing rates of obese people, advancements in technology in surgeries, increasing demand for retaining beauty and youth, and increasing geriatric population.

On the flip side, the soaring cost of these procedures may deter plastic surgery and integumentary system procedures market growth over the forecast period.

Market Segmentation 

The MRFR report offers a wide segmental analysis of the on the basis of plastic surgery and integumentary system procedures market based on end user, application, operating area, and procedure.

Based on the procedure, the plastic surgery and integumentary system procedures market is segmented into skin tests, culture and sensitivity, incisional biopsy, excisional biopsy, and prefilled syringe biopsy.

Based on the operating area, the plastic surgery and integumentary system procedures market is segmented into skin, nose, breast, subcutaneous tissue, and eyelids.

Based on application, the plastic surgery and integumentary system procedures market is segmented into augmentation, skin cancer, athlete’s foot, infection, autograft, allograft, and skin grafts.

Based on the end user, the plastic surgery and integumentary system procedures market is segmented into research institutes, research laboratories, and hospitals and clinics.

Regional Analysis 

By region, the plastic surgery and integumentary system procedures market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific, and the Middle East and Africa. Of these, North America will dominate the market over the forecast period. Factors pushing the growth of the plastic surgery and integumentary system procedures market in the region include growing demand for cosmetic procedures, highest expenditure by government sectors on the healthcare sector, consumers changing lifestyle, growing senior population, growing awareness about surgical procedures, and early adoption of new medical technologies.

The plastic surgery and integumentary system procedures market in Europe is projected to have the second-largest share during the forecast period. Factors pushing the growth of the plastic surgery and integumentary system procedures market in the region include increasing rates of surgeries owing to changing lifestyles, increasing research and development activities, and increasing support and funding from the government to the healthcare sector.

The plastic surgery and integumentary system procedures market in the APAC region is projected to have a favorable growth during the forecast period. Factors pushing the growth of the plastic surgery and integumentary system procedures market in the region include the availability of high-quality services, budding medical tourism, high access to technology, and improving healthcare infrastructure.

The plastic surgery and integumentary system procedures market in the MEA is projected to have a small share during the forecast period owing to poor medical facilities, lack of technical knowledge, and underdeveloped healthcare sector.

Key Players 

Notable players profiled in the plastic surgery and integumentary system procedures market report include Scivision Biotech Inc, Integra Lifesciences, Sanofi, Valeant Pharmaceuticals, Allergan, Merz Pharma, Galderma, Lumenis, Alma Lasers, Cynosure Inc., and Allergen Inc.